HAG
REGN icon

HighPoint Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

HighPoint Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Buy
788
+20
+3% +$13.6K 0.02% 475
2026
Q1 		$594K Sell
768
-1,686
-69% -$1.29M 0.02% 392
2025
Q4 		$1.89M Buy
2,454
+1,095
+81% +$744K 0.04% 324
2025
Q3 		$764K Sell
1,359
-222
-14% -$126K 0.04% 307
2025
Q2 		$830K Sell
1,581
-43
-3% -$24K 0.04% 273
2025
Q1 		$924K Sell
1,624
-173
-10% -$119K 0.05% 246
2024
Q4 		$1.2M Sell
1,797
-296
-14% -$248K 0.07% 219
2024
Q3 		$2.2M Buy
2,093
+25
+1% +$27.8K 0.13% 135
2024
Q2 		$2.23M Buy
2,068
+210
+11% +$204K 0.13% 129
2024
Q1 		$1.81M Buy
1,858
+49
+3% +$46.6K 0.13% 135
2023
Q4 		$1.74M Buy
+1,809
New +$1.49M 0.12% 134
2022
Q2 		$474K Buy
+798
New +$519K 0.05% 301
2021
Q3 		$606K Buy
1,002
+616
+160% +$382K 0.06% 270
2021
Q2 		$216K Buy
+386
New +$196K 0.02% 484
2021
Q1 		– Sell
-601
Closed -$295K – 536
2020
Q4 		$295K Buy
601
+200
+50% +$108K 0.04% 354
2020
Q3 		$236K Buy
401
+14
+4% +$8.49K 0.04% 317
2020
Q2 		$236K Buy
387
+19
+5% +$10.8K 0.05% 286
2020
Q1 		$208K Buy
+368
New +$152K 0.05% 290
2019
Q4 		– Sell
-348
Closed -$118K – 454
2019
Q3 		$118K Buy
348
+1
+0.3% +$296 0.03% 431
2019
Q2 		$102K Buy
+347
New +$116K 0.02% 457
2017
Q3 		– Sell
-7,380
Closed -$424K – 289
2017
Q2 		$424K Hold
7,380
– – 0.14% 179
2017
Q1 		$424K Buy
+7,380
New +$2.74M 0.14% 179

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HighPoint Advisor Group's REGN Position: Q2 2026 in Review

HighPoint Advisor Group increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q2 2026, buying an estimated $13.6K and bringing the position to 788 shares worth $492K. The position accounts for 0.02% of the portfolio, ranked #475.

HighPoint Advisor Group first reported a position in REGN in Q1 2017 and has held it in 22 quarters since. The position peaked at $2.23M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • HighPoint Advisor Group held 788 shares of Regeneron Pharmaceuticals worth $492K as of Q2 2026.
  • HighPoint Advisor Group bought 20 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $13.6K.
  • Regeneron Pharmaceuticals made up 0.02% of HighPoint Advisor Group's portfolio in Q2 2026, its #475 holding.
  • HighPoint Advisor Group first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 22 quarters since.
  • HighPoint Advisor Group's Regeneron Pharmaceuticals position peaked at $2.23M in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.